<DOC>
	<DOCNO>NCT02044614</DOCNO>
	<brief_summary>1 . To assess feasibility safety apply 12-week course adjuvant low-frequency icodextrin-based peritoneal dialysis ongoing regimen thrice-weekly in-center hemodialysis . Hypothesis : Icodextrin-based peritoneal dialysis safely feasibly implement context ongoing thrice-weekly in-center hemodialysis . 2 . To measure effect 12-week course adjuvant low-frequency icodextrin-based peritoneal dialysis ongoing thrice-weekly maintenance hemodialysis : inter-hemodialytic weight gain , achievable hemodialytic dry weight , total body water , ambulatory blood pressure , serum phosphorus , pre-to-post hemodialysis change serum potassium pH , Kidney Disease Quality Life-SF physical functioning , energy fatigue , general health score . Hypotheses : Addition adjuvant icodextrin-based peritoneal dialysis : 1. reduce inter-hemodialytic weight gain* 2. enable achievement lower hemodialytic dry weight 3. reduce total body water 4. improve ambulatory blood pressure control 5. reduce serum phosphorus 6. minimize per-hemodialytic change serum potassium pH 7. favorable effect index physical function global health - Indicates co-primary outcome .</brief_summary>
	<brief_title>Adjuvant Peritoneal Dialysis Background Thrice-Weekly Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Icodextrin</mesh_term>
	<criteria>patient functionally anuric ( urine volume &lt; 100ml/day ) receive chronic maintenance dialysis treatment endstage renal disease transition hemodialysis ( HD ) peritoneal dialysis ( PD ) transition PD HD receive PD functional arteriovenous access already place &lt; 18 year age anticipate living related kidney transplant transfer care away participate unit within next 6 month anticipate survival &lt; 6 month contraindication PD therapy history complicate bowel abdominal aortic surgery know abdominal wall defect pregnancy ( include premenopausal woman surgically sterilize hormonal contraception ) indwell transabdominal prosthetic device ( e.g. , feed biliary tube ) know hypersensitivity peritoneal dialysate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Hemodialysis/Peritoneal Dialysis</keyword>
	<keyword>functionally anuric</keyword>
	<keyword>Icodextrin</keyword>
	<keyword>Kidney Disease Quality Life</keyword>
</DOC>